RCA-101

N/A

Report date: 2024/11/13 10:07:35

Base Information

Drug NameRCA-101
Drug Alias NameRCA-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognigenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCognigenics Inc
Inactive CompaniesN/A
Active IndicationsAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A